IQVIA to Provide Sanofi Its Orchestrated Customer Engagement (OCE) Platform in Africa & Middle East
23 10월 2023 - 9:00PM
Business Wire
Sanofi to use IQVIA’s CRM platform to maximize
customer interactions and innovate in the retail channel
IQVIA™ (NYSE:IQV), a leading global provider of advanced
analytics, technology solutions and clinical research services to
the pharmaceutical and broader life sciences industry, today
announced that Sanofi will use the IQVIA OCE platform in select
countries across Africa and the Middle East.
IQVIA OCE is a next-generation life sciences commercial platform
that connects all customer-facing functions to deliver more
personalized and optimized customer experiences. OCE delivers
best-in-class CRM for life science companies that is built and
maintained on the latest Salesforce technology. Powered by IQVIA
Connected Intelligence™, OCE accelerates decision making with
greater accuracy and scale through embedded intelligence providing
real-time contextual insights, AI-driven recommendations, and
predictive outcomes.
“Sanofi Consumer Healthcare has been using IQVIA in many markets
to support our HCP engagement. OCE comes as the natural solution to
accelerate our omnichannel strategy to interact with our Customers
and Healthcare partners," says Micah Naidoo, Head for Africa,
Middle East & Turkey, Consumer Healthcare, Sanofi.
“IQVIA has a longstanding relationship with Sanofi, and we are
delighted to provide our OCE platform for their advanced customer
engagement needs,” said Peter Lane, Senior Vice President and
General Manager, Africa, Middle East and South Asia, IQVIA. “OCE
will help Sanofi’s Consumer Healthcare Global Business Unit deliver
a more orchestrated customer experience for its business,
optimizing engagement across all personal and digital
channels.”
About IQVIA
IQVIA (NYSE:IQV) is a leading global provider of advanced
analytics, technology solutions, and clinical research services to
the life sciences industry. IQVIA creates intelligent connections
across all aspects of healthcare through its analytics,
transformative technology, big data resources and extensive domain
expertise. IQVIA Connected Intelligence™ delivers powerful insights
with speed and agility — enabling customers to accelerate the
clinical development and commercialization of innovative medical
treatments that improve healthcare outcomes for patients. With
approximately 87,000 employees, IQVIA conducts operations in more
than 100 countries.
IQVIA is a global leader in protecting individual patient
privacy. The company uses a wide variety of privacy-enhancing
technologies and safeguards to protect individual privacy while
generating and analyzing information on a scale that helps
healthcare stakeholders identify disease patterns and correlate
with the precise treatment path and therapy needed for better
outcomes. IQVIA’s insights and execution capabilities help biotech,
medical device and pharmaceutical companies, medical researchers,
government agencies, payers and other healthcare stakeholders tap
into a deeper understanding of diseases, human behaviors and
scientific advances, in an effort to advance their path toward
cures. To learn more, visit www.iqvia.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231023209694/en/
Nick Childs, IQVIA Investor Relations (nick.childs@iqvia.com)
+1.973.316.3828
Trent Brown, IQVIA Media Relations (trent.brown@iqvia.com)
+1.919.780.3221
IQVIA (NYSE:IQV)
과거 데이터 주식 차트
부터 4월(4) 2024 으로 5월(5) 2024
IQVIA (NYSE:IQV)
과거 데이터 주식 차트
부터 5월(5) 2023 으로 5월(5) 2024